The impact of MFG-E8 in chronic pancreatitis: potential for future immunotherapy?

D'Haese J. G. , Demir I. E. , Kehl T., Winckler J., Giese N. A. , Bergmann F., ...Daha Fazla

BMC GASTROENTEROLOGY, cilt.13, 2013 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1186/1471-230x-13-14


Background: The glycoprotein MFG-E8 mediates phagocytic clearance of apoptotic cells and influences the pathogenesis and progression of inflammatory diseases. MFG-E8 was shown to attenuate the progression of inflammation and to improve survival in septic rats. Accumulating evidence suggests an immunomodulatory link between MFG-E8 and the pro-inflammatory chemokine fractalkine, which may determine the severity of pain, fibrosis, and inflammation in chronic pancreatitis (CP).